Cannabis et troubles psychotiques (notice n° 675829)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03950cam a2200313 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250121201504.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Blecha, Lisa |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Cannabis et troubles psychotiques |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2009.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 24 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | RésuméEn France, le cannabis est le produit illicite le plus consommé. En 2005, 3,9 millions de français entre 15 et 75 ans avaient au moins un usage dans l’année. Le cannabis est utilisé depuis les temps anciens dans la pharmacopée médicale pour ses propriétés antispasmodiques et analgésiques, d’où la perception courante d’un remède naturel. Les études ont montré que le cannabis est associé avec une moindre santé physique et psychique.Les liens entre le cannabis et les troubles psychotiques sont subtils. Le cannabis est souvent consommé pour ses propriétés anxiolytiques, psychostimulantes et hallucinogènes. Les recherches récentes en imagerie, neurobiologie, neurophysiologie et génétique incriminent de plus en plus le système endocannabinoïde dans la genèse des troubles psychotiques. Cet article propose de faire le parallèle entre les troubles psychotiques liés à l’usage du cannabis, la schizophrénie et les données de la recherche pourront expliquer certains des liens observés. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Cannabis and psychotic disordersIn France, cannabis is the most widely consumed illegal substance. In 2005, 3.9 million French between the ages of 15 and 75 used the drug at least once during the year. Cannabis has been used since ancient times in medical pharmacopoeia for its antispasmodic and analgesic properties, accounting for the current perception of cannabis as a natural remedy. Studies have shown that cannabis is associated with a reduction in physical and mental health.The links between cannabis and psychotic disorders remain unclear. Cannabis is frequently consumed for its anxiolytic, psychostimulant or hallucinogenic properties. Recent research in imagery, neurobiology, neurophysiology and genetics, incriminate endocannabinoids more and more in the genesis of psychotic disorders. This article proposes to draw a parallel between psychotic disorders linked to the use of cannabis, schizophrenia and research results which may explain certain observed links. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Cannabis et trastornos psicóticosEn Francia, el cannabis es el producto ilícito más consumido. En 2005, 3,9 millones de franceses entre 15 y 75 años lo habían consumido por lo menos una vez en el año. El cannabis está utilizado desde muy antiguo en la farmacopea médica por sus propiedades antiespasmódicas y analgésicas, de ahí que se le suela ver como un remedio natural. Los estudios han demostrado que el cannabis va emparejado con menos salud física y psíquica.Los vínculos entre cannabis y trastornos psicóticos son sutiles. El cannabis muchas veces se consume por sus propiedades anxiolíticas, psicoestimulantes y alucinógenas. Las últimas investigaciones en Imagen, neurobiología y genética apuntan cada vez más al sistema endocannabinoide en la génesis de los trastornos psicóticos. Este artículo propone poner en paralelo por un lado los trastornos psicóticos relacionados con el uso del cannabis, y por otro con la esquizofrenia. Los datos aportados por la investigación podrán explicar algunos de los vínculos observados. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vulnérabilité |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | psychose |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cannabis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tétrahydrocannabinol |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | schizophrénie |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | schizophrenia |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cannabis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | psychosis |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vulnerability |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | tetrahydrocannabinols |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Benyamina, Amine |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | L'information psychiatrique | Volume 85 | 7 | 2009-09-01 | p. 641-645 | 0020-0204 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-l-information-psychiatrique-2009-7-page-641?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-l-information-psychiatrique-2009-7-page-641?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux